Recently Published Documents
(FIVE YEARS 94)
(FIVE YEARS 6)
Comprehensive analyses of the inotropic compound omecamtiv mecarbil in rat and human cardiac preparations
Vol 11 (2) ◽
Population Pharmacokinetic Properties of Omecamtiv Mecarbil in Healthy Subjects and Patients with Heart Failure with Reduced Ejection Fraction
Vol Publish Ahead of Print ◽
Corrigendum to ‘Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials’ [ Eur J Heart Fail 2020;11:2160–2171]
Faculty Opinions recommendation of Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
Faculty Opinions recommendation of Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF.
Generative adversarial networks for construction of virtual populations of mechanistic models: simulations to study Omecamtiv Mecarbil action
Vol 16 ◽